Significantly, hsa_circRNA_001676 could affect CRC progression via targeting miR-556-3p/G3BP2 axis, suggesting that hsa_circRNA_001676 may become a potential therapeutic target in treating CRC. Here, G3BP2 is linked to colorectal carcinoma.